Redefining healthcare education: Perspectives and accomplishments by Harrison, Brian G. & Barchi, Robert L.
Thomas Jefferson University
Jefferson Digital Commons
Thomas Jefferson University Administrative
Documents and Reports Thomas Jefferson University
July 2007
Redefining healthcare education: Perspectives and
accomplishments
Brian G. Harrison
Thomas Jefferson University
Robert L. Barchi
Thomas Jefferson University
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/tjuadmin
Part of the Health Services Administration Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Thomas Jefferson University Administrative Documents and Reports by an authorized administrator of the Jefferson Digital Commons. For more
information, please contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Harrison, Brian G. and Barchi, Robert L., "Redefining healthcare education: Perspectives and
accomplishments" (2007). Thomas Jefferson University Administrative Documents and Reports. Paper 5.
http://jdc.jefferson.edu/tjuadmin/5
Thomas Jefferson University
2 0 0 7  A n n u a l  R e p o r t
Redefining Healthcare Education
Perspectives and Accomplishments
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Mission
Thomas Jefferson University is dedicated to
the health sciences.We are committed to:
• Educating professionals in a variety of 
disciplines who will form and lead the 
integrated healthcare delivery and
research teams of tomorrow
• Discovering new knowledge that will 
define the future of clinical care through
investigation from the laboratory to the
bedside, and into the community
• Setting the standard for quality,
compassionate and efficient patient care 
for our community and for the nation
We accomplish our mission in partnership
with Thomas Jefferson University Hospitals,
our education and clinical care affiliate.
Vision
• To be among the premier educators of
healthcare practitioners in the nation
• To be a leading innovator in the provision
of compassionate clinical care 
• To be a major center for patient-oriented
research and clinical trials
• To be a knowledge leader in selected 
areas of basic research
On the Cover: The Dorrance H. Hamilton Medical Education Building is an impressive, 136,000 
square-foot, state-of-the-art facility that supports a restructured curriculum which brings together 
students from Jefferson’s three colleges to learn in an environment that employs integrated teaching
modalities and simulated team experiences. It will position Jefferson to prepare a greater number of
health professional students to meet regional and national changes and growing healthcare needs. 
Also pictured are Elisabeth J. Van Bockstaele, PhD, Professor, Department of Neurological Surgery, 
top, David B. Nash, MD, MBA, Chair, Department of Health Policy, center, and Vijay Rao, MD, Chair,
Department of Radiology, bottom.
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With pride and distinction, for 183 years, Thomas Jefferson University has
educated and nurtured some of the brightest leaders in the healthcare field.
The opening of the Dorrance H. Hamilton Medical Education Building in
October 2007 places our new education facilities at the very heart of our
campus to support our core teaching mission and marks another critical
chapter in our longstanding history at the forefront of medical education.
To support our academic mission, the long-term plan, developed in con-
junction with our clinical partner, Thomas Jefferson University Hospitals,
is already transforming Jefferson’s campus into a more visibly recognized
community for learning and clinical care. 
To attract the brightest students, Jefferson is increasing the number of
scholarships offered, through the creation of the Eakins Legacy fund that
provides matching funds for endowed chairs and scholarships.
Our research scientists have made numerous discoveries that have gone
from the laboratory to the patient bedside and out into the community. Our
investigational studies will continue our emphasis in the areas of cancer
and cancer biology; cardiac and cardiovascular biology; neuroscience,
population and public health; and infectious diseases and vaccines. 
Jefferson’s future success not only depends on realizing our research,
education and patient care goals, but it is also reliant on the continued
dedication of our faculty and employees, the commitment of our donors,
the strategic alliances we have formed throughout the community and the
support and vision of our leadership and board members. 
Collective and collaborative – this teamwork has strongly positioned
us today and will continue to move Jefferson forward to achieve our goal
of redefining healthcare.
A message from Brian G. Harrison and Robert L. Barchi, MD, PhD
Robert L. Barchi, MD, PhD
President and Chief Executive Officer
Brian G. Harrison
Chair, Board of Trustees
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Jefferson Medical College received
full accreditation for eight years
from the Liaison Committee on
Medical Education (LCME).
The Jefferson InterProfessional Education Center, created in January 2007, is one of only a few such centers 
in the nation. Director Christine Arenson, MD and Co-Director Molly Rose, RN, CRNP, PhD spearheaded campus-
wide efforts to institutionalize interprofessional education, including didactic instruction, clinical simulation and
skills training, team-based clinical care, faculty development, and networking opportunities. 
The Department of Radiology was ranked first in the 
United States in Resident Education by the American 
Board of Radiology based on cumulative performance 
of Jefferson’s residents over the last five years.
Jefferson Medical College received Accreditation with Commendation
from the Accreditation Council for Continuing Medical Education
(ACCME). Less than 12 percent of all CME providers in the United
States and Canada receive this designation.
2 Thomas Je f fe rson Univers i ty
Education
Accomplishments
Strengthening the Social Contract Between Medicine and Society
Thomas J. Nasca, MD, MACP, The Anthony F. and Gertrude M. DePalma Dean, Jefferson Medical College, Senior Vice President for Academic Affairs, Thomas Jefferson University
I am confident that a Jefferson medical education prepares young physicians
to become the leaders in tomorrow’s healthcare system. That system will be
characterized by complexity and rapid evolution. In order to prepare
students for the challenges in delivering excellent patient-centered care over
careers spanning the first half of the 21st century, we must equip them with
not only knowledge and skills of the rapidly evolving science of medicine,
but also the values and virtues characteristic of the ‘Virtuous Physician.’ 
While knowledge and skills can be taught in the classroom or in simu-
lations of the clinical setting, the affirmation of values is best learned in the
care of patients at the shoulder of superior clinicians who model virtuous
behaviors. The fundamentals of principle based ethics: Beneficence,
Justice, Non-Malificence, and Autonomy; coupled with the virtues of
Altruism, Benevolence, Compassion, Courage, Humility, Integrity and
Intellectual Honesty are the underpinnings of the behaviors and actions of
the Virtuous Physician. 
At Jefferson, we are as serious about excellence in values as we are about
excellence in surgery. We are as serious about knowing how to help a person
cope with his or her illness as we are about making the proper diagnosis. 
Caring about and for our patients is our legacy, and teaching the next
generation of physicians our values is our responsibility. 
Professional principles and values are the broad-based levers which
influence the direction of our complex system of education, and in the
broader sense our healthcare delivery system. As the facts and technologies
evolve, the principles and values remain durable. They provide the con-
ceptual scaffolding which places the patient at the center of our activities,
and continually draw on and reinforce the altruistic and empathetic ten-
dencies of our students, faculty, and practitioners. Our faculty reinforce
that medicine is a freely given service, rather than a task.
There is no question that the values and principles that underlie
Virtuous behavior and ethical deportment are not options, but part of the
core responsibilities of every physician, regardless of specialty. These values
are the common bond among members of the profession. They are the
basis for the social contract between medicine and society, and the glue
that creates the trust between the profession and society. These principles
and values are what the Faculty of Jefferson Medical College stand for and
aspire to demonstrate each day and, through our actions, inculcate in our
students the desire to become Virtuous Physicians. 
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Thomas J. Nasca, MD, MACP, Dean of Jefferson Medical
College, with Jefferson Medical College students from
left, Amber Johnson, Samuel Grodofsky, Andrew Rosner
and Kenika Robinson.
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As part of Jefferson College of Health Professions’ efforts to support our
enterprise-wide goal of becoming a comprehensive academic health
institution, we continue to move our programs toward higher-end compe-
tencies in key health professions, as well as to offer new degreed curricula. 
We achieved significant milestones in 2007. It marks the second year of
record-breaking enrollment; we graduated the first class to earn its Doctor
of Physical Therapy (DPT) – a program combining classroom work with
clinical experiences to prepare students to practice in all clinical areas of
physical therapy; and, collaborating with the Council for Relationships, we
developed a master’s level curriculum in Couple and Family Therapy. 
In September, the college also enrolled students in newly developed
doctoral programs in nursing (DNP) and occupational therapy (OTD).
These dedicated students will have the opportunity to achieve a degree of
specialization that does not exist at the master’s level. Their higher level of
training and expertise will make them more valuable as clinicians and as
teachers within an interdisciplinary setting. 
We also continue to drive forward our plans to offer Doctor of Pharmacy
(PharmD) degrees at our School of Pharmacy slated to open in 2008. 
I am pleased to report that Jefferson College of Health Professions is
uniquely positioned for strategic growth and development, and to meet the
demand for superbly trained professionals to staff and train tomorrow’s
integrated healthcare delivery teams.
Growing on All Fronts to Meet the Ever-Expanding Demand for Health Professionals
James B. Erdmann, PhD, Dean, Jefferson College of Health Professions
Education
Recent Nursing graduates (MSN) had a 100 percent 
pass rate on national certification exams and BSN graduates
had a 96 percent pass rate on 2006 licensing exams, well
above the national average of 88 percent.
Jefferson College of Health Professions is the
only institution in the region to offer academic
healthcare programs in cytotechnology, 
biotechnology and medical technology.
Accomplishments
Marcia Levinson, PhD, Assistant Professor of Physical Therapy in the Jefferson College of Health Professions,
teaches OT student Jamilyn Ambrosky, left, and PT student Gillian Blaney, right, to work with children who are
delayed or at-risk for delay to achieve age-appropriate functional activities as part of a Department of Education,
Special Education Programs grant. This grant provides tuition assistance to prepare occupational and physical
therapy students to specialize in early intervention and school-based practice.
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Our new PhD flexible entry pathway allows
entering students to choose among the college’s
eight PhD programs.
Expanded Postdoctoral Fellow 
Research Symposium Day enjoyed 
broad participation by Jefferson 
postdocs.
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Accomplishments
Expertly Launching Tomorrow’s Biomedical Science Explorers Toward Discovery
James H. Keen, PhD, Dean of the Jefferson College of Graduate Studies and Vice President for International Affairs
What makes the Jefferson College of Graduate Studies a supportive and
pioneering home for future discoverers of new knowledge?
It’s our mission to train students to embrace a lifelong passion for discovery.
Discoveries that may revolutionize the way we treat cancer; help patients
with Parkinson’s disease retain their ability to move and function normally;
or lead to an understanding of what triggers autoimmune diseases. 
These future advances start with a thirst for knowledge and leaders who
light the way, sharing their passion and excitement for finding answers to
serve the greater good. Our students benefit from being taught by individuals
who are skilled researchers and teachers, as well as hands-on caregivers
and health practitioners. 
Our goal is to offer PhD, master’s and postdoctoral biomedical science
programs that will prepare our students to meet the challenges of a rapidly
changing research environment. In support of this, our public health
program, now directed by a recognized leader in the field, Robert Simmons,
DPH, MPH, CHES, offers both full-time and part-time options leading
to an MPH degree; our postdoctoral programs are attracting national
attention; our PhD students receive national recognition for their work and
the interdisciplinary orientation of our PhD programs continues to evolve. 
As we grow, sharing our excitement for discovery and educating those
future explorers who may, one day, help all of us lead healthier, more
productive lives has been – and continues to be our singular passion. 
Laurence C. Eisenlohr, VMD, PhD, Professor of
Microbiology and Immunology, top, instructs Jefferson
College of Graduate Studies student, James S. Testa,
center, and post-doctoral fellow, Kerstin Kandler in 
the use of the confocal microscope to review digital
images from a tissue sample.
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The Department of Radiology was ranked 
first in the United States by the Radiology 
Society of North American (RSNA) in research
presentations over the past 10 years.
The Department of Orthopaedic Surgery’s research program
ranked number two in the United States in National Institute
of Health (NIH) funding and number one in the United
States in the number of research grants funded by the NIH.
Urologists are studying whether a neo-bladder construct grown from 
a patient’s own cells can improve bladder function for adult spinal cord
injury patients. Jefferson is only one of six sites in the United States
enrolling participants in the trial that will involve a total of 10 patients.
Jefferson established the Vaccine Center to create
an infrastructure for all of the university’s research
and clinical efforts, while hoping to spur new 
collaboration and innovation.
Accomplishments
A Biomedical Revolution
Steven E. McKenzie, MD, PhD, Vice President for Research
At Jefferson, we are fortunate to be within a short walk of Washington
Square and Independence Hall. Several times a week, I will take a walk
around those places and I am reminded of the intellectual prowess and
courageous action displayed by those who launched the American
Revolution. The impact of the foresight and single-mindedness of purpose
of those individuals has shaped our country into what it is today.
Currently, we are in the midst of a different kind of revolution, but one
that is no less important to the future and well-being of our population –
a biomedical revolution. We are encouraged and inspired by the intellects
of those who are moving a molecular and genetic understanding of disease
into better care of our patients. In all areas of medical specialties, you will
find our biomedical investigators tirelessly searching for improved diag-
nostic evaluations, better treatment options and more desirable outcomes.
The current work of these contemporary explorers and thinkers must
also be perpetuated by the continual training of future scientists – men
and women who will carry on the work and lead the search through the
unknown to what is waiting to be discovered. 
Dr. Scott Waldman has restructured and spearheads Jefferson’s MD/PhD
program, positioning it to compete for National Institutes of Health (NIH)
funding for a Medical Scientists Training Programs grant to expand our
enrollment. The dual-degree program trains future physician scientists,
not just to make discoveries in the lab, but to bring these breakthroughs to
the bedside and, ultimately, into the community – translational medicine
in its purest sense.
Additionally, NIH and Department of Defense funding support the
discovery of Halgeir Ruik, MD, PhD, Professor of Cancer Biology at
Jefferson Medical College and Lynn Neilson, PhD, a postdoctoral fellow in
Cancer Biology, showing that the pituitary hormone prolactin activates
the protein Jak1 to initiate a new “signaling pathway” that may regulate the
growth and survival of breast cancer cells. The scientists are investigating
the potential usefulness of Jak1 as a new drug target for patients. 
A shining example of translational medicine–one that truly goes beyond
the bedside into the community–is the work of Dr. Kathleen Squires. She is
leading a new wave of approaches to treating HIV/AIDS in the community
through Jefferson’s recently unveiled HIV/AIDS clinic, which she jointly
manages with Dr. Joseph DeSimone. Reaching out to community-based
organizations, minority groups and local healthcare centers, Dr. Squires
treats patients as well as educates Jefferson residents and fellows in the care
and complexity of the HIV/AIDS patient.
In medicine, our challenges are many: from infectious diseases to cancer to
reduced research funding. However, let us draw from the dedication of tal-
ented Jefferson researchers and join the excitement of this new revolution.
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Steven E. McKenzie, MD, PhD, Professor of
Medicine and Pediatrics and Vice President for
Research visits Carpenter’s Hall, an iconic
Philadelphia landmark representing a revolutionary
time in history, and a symbolic foreshadowing 
of the evolution of research.
Kathleen Squires, MD, Director, Division of Infectious
Diseases, Department of Medicine, left, and Joseph A.
DeSimone Jr., MD care for patients with a wide variety 
of infectious diseases such as AIDS, Lyme Disease,
Osteomyelitis, Endocarditis, and Chronic Fatigue Syndrome.
The Division also has an active clinical research program 
that brings state-of-the-art treatments to patients.
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Using zebrafish, radiation oncologist
Adam P. Dicker, MD, PhD, has shown that
nanoparticles can regulate damage to
normal tissue from radiation.
Kimmel Cancer Center at Jefferson cancer biologists directed
by Arthur Buchberg, PhD, and Linda Siracusa, PhD, found 
a mutation in the gene Atp5a1 can reduce the number of
colon polyps and potentially cut the risk of cancer.
A multi-institutional team including Jefferson microbiologist and immunologist
Linda D. Siracusa, PhD, and research associate Cinzia Sevignani, PhD, discovered
new evidence indicating that small pieces of non-coding genetic material known
as microRNAs might influence cancer susceptibility.
Led by Richard G. Pestell, MD, PhD, FRACP,
Jefferson researchers identified the protein
Akt1 as a key component in helping a
quarter of all breast cancers spread.
8 Thomas Je f fe rson Univers i ty
Research
Accomplishments
Kimmel Cancer Center at Jefferson – an Epicenter of Change
Richard G. Pestell, MD, PhD, FRACP, Professor and Chair of the Department of Cancer Biology, Associate Dean for Cancer Programs, Vice President for Oncology Services, 
and Director of the Kimmel Cancer Center at Jefferson
Integrated, multidisciplinary clinical care, research, education and training
are what Jefferson and the Kimmel Cancer Center are all about. No program
is guided by that mission more than the Kimmel Cancer Center. The growth
in staff, programs and funding is key to our success in our work against
cancer. That’s why I am so excited to share our center’s outstanding progress
with you. 
The magnitude of change here and the commitment to the biomedical
infrastructure are apparent in increased new discoveries and improved
patient care. Over the last two years, we have experienced a doubling of
investigator-initiated clinical trials, growth in the Jefferson Cancer
Network membership and significant new clinical research projects.
Since joining Jefferson two years ago, the center has recruited 55 new
full-time faculty members, stimulated an approximate doubling of NCI
grant funding and formed two new programs in breast and prostate cancer
and radiation oncology and radiology. New eminent cancer researchers
bring passion, curiosity and distinguished research achievements to
Jefferson’s fight against cancer. We have been granted more than 50
pioneering patents for cancer discoveries. 
One of the leading cell biologists in the world is a new member of the
Kimmel Cancer Center at Jefferson. Michael P. Lisanti, MD, PhD, Professor
of Cancer Biology, identified by Thomson Scientific as the last decade’s
13th most cited researcher, is studying the Caveolin-1 (Cav-1) gene
mutation, shedding light on how breast cancer develops and what can be
done to alter the process. His Kimmel Cancer Center team discovered the
most common mutation in estrogen receptor expressing human breast
cancer which occurs in the Cav-1 gene. Dr. Lisanti is also investigating
whether the Cav-1 mutation may relate to therapy resistance.
Clinical pharmacologist Scott A. Waldman, MD, PhD, Professor and
Chair of Pharmacology and Experimental Therapeutics, continues his
groundbreaking discoveries in colorectal cancer. His team has shown that
if GCC (guanylyl cyclase C) is present in tumors in other areas of the body,
the cancer is metastatic colon cancer. Additional studies suggest that colon
cancer is a disease of hormone insufficiency and not genetic, leading Dr.
Waldman to explore hormone replacement therapy as a potential method
for treating or even preventing intestinal cancer formation.
As the energetic and dedicated team of scientists at Jefferson’s Kimmel
Cancer Center continues their noteworthy accomplishments, they gain
prominence, prompting more patients to place their trust in Jefferson for
cancer care and prevention.
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Richard G. Pestell, MD, PhD, FRACP, Director of the Kimmel Cancer Center at
Jefferson, left, and Edith P. Mitchell, MD, FACP, Clinical Professor of Medicine
and Medical Oncology, meet with a patient. Led by Dr. Mitchell, a recent
Kimmel Cancer Center at Jefferson study of more than 2,200 diagnosed with
breast cancer, found that African American women have more advanced
breast cancer at the time of diagnosis than Caucasian women.
Michael P. Lisanti, MD, PhD, Professor, Department of 
Cancer Biology, works collaboratively with his team of
researchers to discover new advances and find the 
cure for breast cancer.
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A Jefferson cardiology study found that drug-eluting stents
used for patients with diffuse (extensive) cardiac disease
fare less well in keeping veins open than those used for
patients with focal disease.
Cardiac Catheterization Laboratory researchers have determined
that nicardipine, a calcium channel blocker, is effective in
reversing the “no-reflow” phenomenon that affects as many 
as 50,000 patients who undergo angioplasty annually. 
Center for Translational Medicine scientists have 
staved off heart failure in animals, using gene therapy 
to shut down the adrenal gland’s excessive output of 
epinephrine and norepinephrine. 
Jefferson researchers discovered that Plavix®, 
when used in addition to aspirin, does not worsen
bleeding after off-pump heart bypass surgery. 
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Accomplishments
Pioneering New Treatment Strategies
Arthur Michael Feldman, MD, PhD, Magee Professor and Chair of Medicine
Identified as the disease responsible for the most deaths of both men and
women in the United States, cardiovascular disease remains an important
focus for the Jefferson Heart Institute. By leveraging an array of talent and
resources, our cardiovascular disease treatment approach targets all
fronts. Our primary goal is developing new diagnostic tests and treatment
strategies by closely linking laboratory research and discovery with
observations and treatments at the patient’s bedside.
A team led by Thomas G. Force, MD, PhD, The James C. Wilson Profes-
sor of Medicine and Clinical Director of the Center for Translational
Medicine, has found that a new generation of cancer-fighting drugs called
Tyrosine kinase inhibitors (TKI) – such as Gleevec® – can have potentially
fatal toxicities to the heart. Dr. Force has found that patients with early
symptoms of heart toxicity while on these types of drugs can resume cancer
treatment if the therapy is temporarily withdrawn and appropriate heart
drugs are administered. To learn more about how to care for these chal-
lenging patients, with M.D. Anderson and other facilities, Jefferson is
leading a multicenter registry for patients receiving potentially cardiotoxic
anti-cancer drugs. 
Jefferson is also pioneering the study of pervasive conditions, such as
obesity, that are major risk factors for the development of cardiovascular
disease. For example, Bonita Falkner, MD, Professor of Medicine and
Pediatrics, is seeking to identify biomarkers that protect against obesity-
related diseases, as well as to find those that predict tissue injury. With
a $4 million grant from the Commonwealth of Pennsylvania’s national
tobacco settlement, Dr. Falkner leads the Jefferson Center of Excellence
(COE) in identifying those genetic markers that may, one day, pave the
way for early intervention in obesity-induced cardiovascular disease.
Researchers led by Center for Translational Medicine’s Director Walter
J. Koch, PhD, who also directs the George Zallie and Family Laboratory
for Cardiovascular and Gene Therapy, have used gene therapy to reverse
heart failure in animals. They have also discovered that the gene therapy
changed the geometry of the heart, slowing or even reversing its enlarge-
ment. These novel approaches to treating heart disease will soon be tried
in patients.
Amidst an increasingly complex healthcare system and rapidly shrinking
research funds, the multifaceted paths of our cardiovascular researchers
strive to link the research bench with the patient’s bedside in order to
anticipate and protect patients from the risks of developing cardiovascular
disease and to provide the best possible treatment if they develop disease.
At Jefferson Heart Institute, we dedicate our vision, creativity, and diligence
to this large task.
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Arthur Michael Feldman, MD, PhD, Magee Professor 
and Chair of Medicine, left, and Walter J. Koch, PhD,
Director, Center for Translational Medicine, discuss the
center’s progress in research that may lead to better 
therapies for heart patients.
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A study directed by Assistant Professor of Neurological
Surgery James S. Harrop, MD, showed that 31 percent
of patients with spinal cord injury treated with the
protein Cethrin®, regained at least partial movement
and/or motor function.
Through the leadership of Jay Schneider, PhD, Professor of Pathology,
Anatomy and Cell Biology, and Neurology, scientists are investigating
whether the nutritional supplement, creatine can improve function
and prevent damage to the brain cells of patients with Parkinson’s.
Neurological surgeons led by John K. Ratliff, MD, found that
being obese raises the risk of spinal surgery complications.
The greater the obesity, the higher the risk.
Cancer biologists D. Craig Hooper, PhD, and Hilary
Koprowski, MD, showed that blood brain permeability
changes almost always correlate to the severity of damage
to a central nervous system from a disease such as MS.
Accomplishments
Collaborating on All Fronts to Combat Neurological Disease 
Robert H. Rosenwasser, MD, FACS, Professor and Chair of Neurological Surgery 
A.M. Rostami, MD, PhD, Professor and Chair of Neurology
At Jefferson Hospital for Neuroscience, among the most comprehensive
centers for neurological disorders in the nation, our neuroscientists
collaborate in interdisciplinary settings to conduct research and care for
patients who seek relief from the devastating symptoms of neurological
and spinal disease. 
The Acute Stroke Center at Jefferson, directed by Rodney D. Bell, MD,
Professor of Neurology, is the region’s largest and one of the most advanced
in the United States for the diagnosis, treatment and prevention of stroke.
The center’s Brain Attack Program offers treatment that, begun within
six hours of symptom onset, can increase by 50 percent the likelihood of
complete recovery from stroke. 
Jefferson neuroscientists offer patients such exciting therapies as Deep
Brain Stimulation, where neurological surgeon Ashwini D. Sharan, MD,
inserts a stimulator to control Parkinson’s disease tremors, and neurologists
Tsao-Wei Liang, MD, and Daniel E. Kremens, MD, evaluate and select the
patients for treatment and provide continuing care. 
Barry W. Rovner, MD, Professor of Neurology and Professor of  Psychiatry
and Human Behavior, Director of the Alzheimer’s Center for Disease
Research and Care and the Jefferson Geriatric Psychiatry Program, has
witnessed remarkable stabilization using investigational drugs against
Alzheimer’s. With a $3.5 million grant from the Commonwealth of
Pennsylvania’s Tobacco Non-formula Settlement, his team is also developing
a screening method to diagnose dementia in a racially and economically
diverse urban population. In a second study funded by this grant, Laura
Gitlin, PhD, Director of the Center for Applied Research on Aging and
Health (CARAH) and Professor of Occupational Therapy at Jefferson
College of Health Professions, studies how education and support can
improve the life of caregivers and patients with dementia.
In addition, Dr. Rovner’s total $6.5 million grant from the National
Institute of Mental Health and the National Eye Institute funds his
study to prevent depression and improve function in age-related macular
degeneration.
From arterial venous malformation and brain tumor care to headache
and sleep disorders, patients rely on Jefferson’s extraordinary team of
neuroscientists.
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The husband and wife teams of Piera Pasinelli, PhD, Davide
Trotti, PhD, Koichi Iijima, PhD, and Kanae Iijima-Ando, PhD,
recently joined the Farber Institute for Neuroscience, Jefferson’s
premier research facility for nervous system diseases. These four
faculty members are accomplished senior researchers whose
work spans basic, translational and clinical science, with a strong
emphasis on molecular and cellular neurobiology and genetics.
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A new guide on pancreatic cancer, co-written by Charles J. Yeo, MD, Samuel 
D. Gross Professor and Chair of Surgery, offers a better understanding to patients
and caregivers of the unique challenges associated with a diagnosis of pancreatic
cancer. Understanding Pancreatic Cancer: A Guide for Patients and Caregivers is
published by the Lustgarten Foundation for Pancreatic Cancer Research. 
Cardiology and Cardiac Surgery faculty received
UNOS certification for the Cardiac Transplantation
Program, and successfully implanted the first Jarvik
2000® artificial heart in the region.
The Department of Rehabilitation Medicine
received continuing funding for the oldest spinal
cord injury model system program in the United
States, continually funded since the late 1970s.
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Accomplishments
Setting the Standard for Efficiency and Patient Safety 
William M. Keane, MD, The Herbert Kean, MD, Professor and Chair of Otolaryngology – Head and Neck Surgery, and Medical Director of Jefferson University Physicians
Improving the patient experience is not just our wish, it’s a mandate at
Jefferson which we take very seriously. We know that quality patient care
demands a compassionate healthcare team, supported by sophisticated
technology in a user-friendly accessible environment.
For the past several months, we have been researching and studying ways
in which we can streamline our processes in order to provide patients with
the standard of outpatient care they deserve. As part of this quest, we have
turned to the technology of the Electronic Medical Record.
This digital health record is a paperless chart management system
wherein patients’ information – health history, allergies, lab results, images,
prescriptions, and other key information–can be electronically stored and
securely accessed by health practitioners involved in their care. It eliminates
the need for paper charts, multiple copies of test results, and reiteration of
health information by the patient. 
This portable health information repository is transferable to different
caregivers, making it easy for the patient to take possession of his or her
personal health record should that patient move or leave the Jefferson
system. In addition, our physicians will be able to accept other digital
records–or scan in traditional paper forms–from previous medical visits.
Imagine just how convenient it would be for a patient to have web
access to his or her record. Not having to fill out the plethora of insurance,
emergency contact and health background information required by each
new doctor appointment will be a welcome change for everyone.
As a physician, I embrace this technology because I believe it creates
time for more interaction with our patients. In addition, its trending and
graphing features would allow me to visually show my patient how his
or her test results have remained the same, or changed over time. As a
researcher, I’m excited to think about the boundless potential for its use in
tracking a population of patients with a certain disease and how we can
study and use that information to improve many lives.
We look forward to piloting our Electronic Medical Record in the spring
of 2008, but even more, we look forward to improving our patients’
experiences when selecting Jefferson healthcare.
Sleep disorder and ear, nose and throat specialists examined an innovative 
procedure, known as Genial Bone Advancement Trephine (GBAT), to treat 
obstructive sleep apnea syndrome. In the procedure, a small portion of the lower 
jaw which attaches to the tongue is moved forward, increasing the airway space. 
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William M. Keane, MD, The Herbert Kean, MD, Professor and Chair 
of Otolaryngology – Head and Neck Surgery and Medical Director of
Jefferson University Physicians, led the quest in the development and
implementation of the Electronic Medical Record, set to pilot in 2008.
Here, Dr. Keane, left, demonstrates the use of the EMR to Matthew C.
Miller, MD, Chief Resident, Department of Otolaryngology – Head and
Neck Surgery, right, and Jennifer H. Carey, CRNP, CORLN.
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A five-year business planning initiative draws the
blueprint for Jefferson University Physicians’ future
strategy and provides supporting data for the
planned ambulatory care building.
A clinical program partnership with Frankford Health
System established a Jefferson University Physician 
presence in the Bucks County area.
Jefferson University Physicians’ (JUP) multidisciplinary
Sleep Center partnership with Methodist Hospital 
created an innovative funds flow model aligning the
financial incentives of JUP with Methodist.
Jefferson University Physicians initiated the Center 
for Medicare and Medicaid Services’ PQRI (Physician
Quality Reporting Initiative) program for the largest 
primary care practices and many subspecialties.
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Patient Care
Accomplishments
The forthcoming implementation of the Electronic Medical Record (EMR)
technology is an exciting leap forward. Exciting as it is, however, it is really
just the tool that was the impetus for our total clinical transformation and
comprehensive business process redesign.
While researching the product and consulting with other academic
healthcare facilities, it quickly became apparent that we needed first to
re-examine and redefine Jefferson University Physicians’ care delivery
model. Learning from the mistakes of others, we knew we couldn’t simply
implement a technology that potentially could be inconsistent with
Jefferson’s current needs and processes. Optimizing our clinical processes
meant looking at our workflow and practices from beginning to end and
determining the best way to retool our system.
We recognized that it is critical that this new system of care be more
responsive to both patient and staff needs; improve the quality, safety and
services that Jefferson provides; standardize processes with room for
common-sense flexibility; protect the privacy and security of patient
information; and support sustainable change. As an academic institution,
we feel it is our responsibility and mission to analyze how to optimally
integrate best practice management techniques and to educate all our staff
members to utilize this system to its full potential.
To achieve these sweeping goals, we solicited input from all levels of
Jefferson staff – physicians, administrators, nurses, technologists – so we
could design a system that could best meet the needs of all. Along with
re-engineering the system, we’re studying how to best implement it and
train our staff to get the greatest benefit from this transformation. Our
patients’ experiences will surely improve from consistent and streamlined
practices.
With physician and staff participation in the development process, we’ve
all become integrated partners in this endeavor to improve our care delivery
system. Embracing this new technology and continuing to focus on an
improved all-around experience for our patients are common goals for
our staff as individuals, as well as proud members of the Jefferson team. 
Clinical Transformation and Business Process Redesign
John Ogunkeye, MS, Executive Director of Jefferson University Physicians 
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Maureen K. McDade, Senior Director, Operations,
left, and John Ogunkeye, Executive Director and
Vice President for Business Affairs, Jefferson
University Physicians, discuss the Electronic 
Medical Record and the benefits it will provide 
for Jefferson University Physicians.
Karen Javie, RN, MSN, Vice President for Strategic Initiatives,
left, and Chris Smith, RN, Director of JEFF NOW ®, played an
instrumental role in the Emerging Technology Committee
whose purpose was to introduce and explore new and 
current technology and integrate it into operations.
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Financials
Operating Revenues
• Physicians’ professional services 37.8%
• Grants and contracts 22.3%
• Tuition and Fees 11.3%
• Sales from auxiliary activities 19.3%
• Endowment payout 1.2%
• State appropriations 1.9%
• Contributions 0.5%
• Other sources 5.6%
Operating Expenses
• Salaries and wages 53.3%
• Employee and faculty benefits 12.1%
• Depreciation 3.1%
• Heat, light and power 3.3%
• Debt service 1.1%
• Other 27.1%
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Thomas Jefferson University
June 30, 2007 and 2006 ($ in Millions)
How We Received Our Revenues 2007 2006
Physicians’ professional services 215.8 203.2 
Grants and contracts 127.2 126.0
Tuition and Fees 64.3 58.0
Sales from auxiliary activities 110.0 103.2
Endowment payout 7.1 6.6
State appropriations 10.8 10.5
Contributions 3.1 2.2
Other sources 31.9 29.5
Operating Revenues $570.2 $539.2
How We Spent Our Revenues
Salaries and wages 295.9 284.9
Employee and faculty benefits 67.4 63.6
Depreciation 17.1 17.3
Heat, light and power 18.2 17.1
Debt service 6.2 6.2
Other 150.6 144.5
Operating Expenses $555.4 $533.6
Subtotal $14.8 $5.6 
Non-operating Gains/(Losses), Net $62.4 $13.0 
Net Income/(Loss) $77.2 $18.6
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Thomas Jefferson University is committed to providing equal educational and
employment opportunities for all persons, without regard to race, color, national,
and ethnic origin, religion, sexual orientation, sex, age, handicap, or veteran’s 
status. Thomas Jefferson University complies with all relevant local ordinances 
and state and federal statutes in the administration of its educational and 
employment policies and is an Affirmative Action Employer.
For additional copies of the Thomas Jefferson University Annual Report, please 
call 215-955-6204, or read the report online at www.Jefferson.edu
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